嬰兒安撫建議描述：：Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) 8-K Current report, item 5.02 Accession Number: 0001104659-22-103164  Act: 34  Size: 193 KB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001104659-22-126446  Act: 34  Size: 677 KB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) 8-K Current report, item 3.01 Accession Number: 0001104659-22-092803  Act: 34  Size: 196 KB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-22-120986  Act: 34  Size: 225 KB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-22-129742  Act: 33  Size: 804 KB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-22-089401  Act: 34  Size: 330 KB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-22-003131  Act: 34  Size: 5 MB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) 8-K Current report, item 1.02 Accession Number: 0001104659-22-110309  Act: 34  Size: 195 KB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-22-089426  Act: 33  Size: 300 KB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-22-099500  Act: 34  Size: 238 KB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-22-002292  Act: 34  Size: 5 MB 網頁鏈接 Marker Therapeutics(MRKR)： Marker Therapeutics(MRKR) 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-22-086190  Act: 34  Size: 259 KB 網頁鏈接